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Background: Anti-hepatitis C virus (HCV) responses are often accompanied by an increase in alanine
aminotransferase levels in HCV-infected patients, indicating that inflammatory responses are compromised by the
virus. Additionally, inflammation is associated with M1-polarizated macrophages, which secrete cytokines such as
tumor necrosis factor-α, interleukin-1, and interleukin-12, and present antigens through phagocytosis. HCV-encoded
proteins are presented as specific viral antigens in particular infectious steps that influence the immune response.
For instance, HCV antigens impact macrophage PD-1 and Tim-3 expression, and contribute to impaired viral
clearance. Furthermore, circulatory HCV antigens from infected patients inhibit dendritic cell differentiation, which
raises the possibility that HCV antigens may also interfere with macrophage polarization.
Methods: In this study, the impact of HCV antigen stimulation on M1-polarized macrophages was investigated.
The influence of HCV antigens was evaluated by reverse transcription polymerase chain reaction and enzyme-linked
immunosorbent assay. Specific changes were investigated clinically by flow cytometry and immunofluorescence.
Effects of NF-κB during the process were analyzed by western blot.
Results: HCV infection dampened M1 macrophage polarization ex vivo and in vitro. After antigen stimulation, NF-κB
signaling was suppressed by the up-regulation of A20 and A20-binding inhibitor of NF-κB binding protein, which
likely leads to a variation of functional molecules such as tumor necrosis factor-α, CD163, matrix metalloproteinases,
transferrin receptor-1, and CD100, reflecting an anti-inflammatory reaction against M1-polarization.
Conclusion: HCV antigens stimulation up-regulates A20/A20-binding inhibitor of NF-κB binding protein expression,
which consequently contributes to inefficient M1 macrophage polarization.Background
Hepatitis C virus (HCV) accounts for millions of viral
hepatitis cases each year [1]. Because most hepatitis
symptoms are mild or even absent, patients often fail to
report chronic infection later in life. Anti-HCV re-
sponses are often accompanied by an increase in alanine
aminotransferase (ALT) levels. Patients exhibit persistent
mild up-regulated ALT in chronic HCV, indicating that
the virus may dampen inflammatory responses. Inflam-
mation is associated with professional antigen presenting
cells (APCs) including dendritic cells (DCs) and macro-
phages that secrete cytokines such as tumor necrosis* Correspondence: jiazsh@fmmu.edu.cn
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for T and B cells to facilitate immune responses [2, 3].
Macrophage-augmented inflammatory responses are as-
sociated with their differentiation and polarization. Mono-
cytes differentiate to act both as phagocytes and APCs,
and are involved in the clearance of pathogen-derived
particles and toxins. Myeloid-derived monocytes migrate
to different tissues through a C-C chemokine receptor 2-
initiated process, and then differentiate into unique mac-
rophages [4, 5]. Two primary macrophage subgroups have
been proposed, termed classically activated macrophages
(M1) and alternatively activated macrophages (M2). The
M1 phenotype is characterized by IL-12hiIL-23hiIL-10lo
expression and iron uptake activity, facilitating inflamma-
tory, microbicidal, and tumoricidal functions. M2 macro-
phages express IL-12loIL-10hiIL-1decoyRhi IL-1RAhi anddistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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sue remodeling and parasite clearance [6–8].
In chronic hepatitis C (CHC), HCV antigen stimulation
leads to profound changes in host immune cells. For ex-
ample, natural killer (NK) cells are directly inhibited by ex-
posure to HCV E2 protein [9–11], while HCV core protein
peptides facilitate HLA-E expression and thereby impair
NK cell cytotoxicity [12, 13]. HCV core and NS3 antigens
activate monocytes to produce IL-10 and TNF-α, as well as
suppress IL-29 secretion, causing a functional inhibition of
DCs [14, 15], and facilitating dimerization of Toll-like
receptors (TLR) 1/2 and 2/6 and hepatic fibrogenesis
[16–19]. Recent experiments indicated that HCV present
in the sera of infected patients interferes with DC differen-
tiation in vitro [20], indicating that such antigens may also
interfere with macrophage function during differentiation.
Studies have shown that HCV antigens influence macro-
phage responses and cytokine expression, alter signaling
receptors and adhesion molecule levels [21–23]. HCV also
influences DC function by modulating their maturation
and cytokine production [24]. Macrophage TLR-3, PD-1,
and Tim-3 expression mediate HCV infection, leading to
dysfunctional macrophage function [25, 26]. However,
whether HCV impacts macrophage polarization is still
poorly understood.
HCV antigens affect macrophages through various
signaling molecules. In this study we analyzed TNF-α,
IL-10, IL-12, transferrin receptor-1 (TfR1), and matrix
metalloproteinases (MMPs) that are highly associated
with macrophage polarization. We examined monocytes
from healthy donors and HCV patients that were iso-
lated and treated with IFN-γ/lipopolysaccharide (LPS) to
stimulate M1 polarization ex vivo. The data indicated
that macrophages from HCV infected patients exhibited
decreased TNF-α and TfR1 expression levels. HCV anti-
gen stimulation of macrophages altered gene expression
associated with M1 polarization, including the expres-
sion of TNF-α, IL-10, IL-12, CD163, TfR1, MMPs and
CD100, as well as inhibition of macrophage phagocytosis
of HCV in cell culture (HCVcc). Furthermore, NF-κB ac-
tivity was abnormally suppressed and A20 with its binding
partner A20-binding inhibitor of NF-κB binding protein
(ABIN1) was up regulated after polarization. A20/ABIN1
overexpression had a similar influence on M1 polarization
compared with HCV antigen stimulation. As the A20/
ABIN1 complex negatively regulates NF-κB signaling
[27, 28], HCV-induced A20/ABIN1 expression likely in-
hibits NF-κB and contributes to abnormal M1-polarization.
Results
Macrophages from HCV-infected patients are polarized
abnormally ex vivo
Peripheral blood mononuclear cells (PBMC) from healthy
donors (n = 29) were cultured with normal medium (HCgroup) or stimulation medium (HS group, containing
HCV-core protein and NS3/4A) for 1 day and were then
treated with LPS/interferon (IFN)-γ for M1 polarization.
Macrophages were then isolated and analyzed by flow cy-
tometry (Fig. 1a). As expected in response to LPS/IFN-γ
challenge, M1 polarization stimulated inflammatory cyto-
kines (TNF-α and IL-12) [29–31], and TfR1 iron uptake
receptors, and down-regulated scavenging receptors
(MARCO, CD163, and CD23) [32–34]. However, com-
pared with normal polarization, HCV antigen stimulation
reduced TNF-α and TfR1 expression (p < 0.001), suggest-
ing suppression of M1 polarization (Fig. 2b). Although
CD163 and CD23 expression was not significantly differ-
ent, a slight up-regulation was observed in some cases.
Macrophages from CHC patients receiving antiviral ther-
apy (PT: n = 32) were also tested. The patients were further
divided into response and no response groups by alanine
aminotransferase (ALT) levels (PTI group: ALT > 40U/L).
Patient PBMCs were cultured with normal medium for
1 day prior to LPS/IFN-γ M1 polarization. Macrophages
isolated and analyzed by flow cytometry showed decreased
TNF-α and TfR1 levels (PT: TNF-α p < 0.001, PTI: TNF-α
p < 0.001 and PTI: TfR1 p < 0.05) (Fig. 1b), indicating im-
pairment of M1-polarization. Nevertheless, CD163 and
CD23 did not show much variation, which may indicate
more complex cell–cell interactions in vivo.
HCV antigens influence macrophage polarization by
different mechanisms in vitro
The impact of HCV antigens on M1 polarization was in-
vestigated using the THP-1 monocyte/macrophage sys-
tem. TNF-α, TfR1, CD163, CD23 and MMP expression
levels were tested. The HCVcc and core protein showed
different effects on TNF-α expression, as HCVcc en-
hanced TNF-α expression and the core protein reduced
TNF-α expression (Fig. 2a). Nevertheless, the main
effects of HCV antigens should be TNF-α inhibition ac-
cording to ex vivo data that showed a decreasing trend
in the patient group. An inhibitory effect was observed
for TfR1 (Fig. 2b and Additional file 1: Figure S1). TfR1
mediates iron endocytosis, but decreased TfR1 expres-
sion resulting from HCV antigen stimulation blocks M1
iron uptake activity. CD163 and CD23 are important
macrophage-specific receptors that switch between acti-
vated phenotypes during inflammation [35]. Although
there was only a small change in CD163 and CD23 ex-
pression ex vivo, both were increased after incubation
with HCV antigens (Fig. 2c, d) in vitro. M1 macrophages
are characterized by high expression levels of TNF-α
and TfR1, as well as low expression levels of CD163 and
CD23. The variation of these molecules may have a
long-term effect on the polarization process.
MMPs generally control extracellular matrix (ECM)
remodeling and have extensive influence on macrophage
Fig. 1 Macrophage phenotypic changes after HCV antigen exposure. Monocytes from healthy donors (HC), healthy donors with HCV antigen
stimulation (HS), treated patients (PT) and patients with liver injury (PTI) were treated with LPS/IFN-γ for polarization before analysis. (a) Gating
strategy. (b) Mean fluorescence intensity (MFI) of TNF-α, TfR1, CD163 and CD23 expression on macrophages. One-way ANOVA was used to determine
statistical significance (*p < 0.05, ***p < 0.001)
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that HCV core protein induced MMP2 expression, while
HCVcc and NS3/4A had little effect. MMP3 expression
decreased after core protein treatment and increased
in NS3/4A-stimulated cells, while MMP7 expression
inhibited HCV core protein and NS3/4A, and HCVcc
stimulated its expression. Interestingly, MMP14 expres-
sion was elevated by all HCV antigens, which represents
nonspecific changes in response to exogenous substances
(Fig. 2e).
We next asked whether HCV stimulated expression of
MMP14 target proteins. MMP14 digests CD100 from the
macrophage cell surface to produce an essential source of
soluble CD100 (sCD100) [37], which is a universal activa-
tor of immune cells. CD100 elicits T and B lymphocytes
and NK cells by inhibiting the inhibitory receptor CD72,
leading to the activation of target cells. sCD100 in particu-
lar detaches from the membrane and diffuses into the
blood, and has greater inflammatory activity than its
membrane form [38, 39]. However, although increased
MMP14 expression increases sCD100 levels, total macro-
phage CD100 expression was restrained after HCV core
and NS3/4A stimulation, suggesting extensive immune
suppression by HCV antigens (Fig. 2f).IL-10 and IL-12 expression levels were also altered in
response to different HCV antigenic stimulation, indicat-
ing that abnormal polarization maybe induced by differ-
ent antigens (Fig. 2g). Interestingly, IL-10 secretion was
decreased following incubation with HCV antigens,
implying a more significant M1-polarization (especially
for the NS3/4A group), whereas HCV core stimulation
reduced IL-12 secretion after polarization, suggesting
impairment of M1-polarization. Macrophages are the pri-
mary source of IL-12 involved in Th1 and Th17 responses,
and increased IL-12 expression is an important character-
istic of M1 polarization [6, 40, 41]. Thus, a decrease in IL-
12 secretion caused by HCV core antigens likely dampens
M1-induced inflammation.
HCV antigen pre-incubation influences A20/ABIN1 complex
in M1 macrophages
Various signaling pathways influence macrophage mat-
uration, including STATS [42–46], MAPK [47–49], and
NF-κB [50, 51]. TLR engagement induces NF-κB activity,
producing inflammatory mediators associated with M1
polarization. Conversely, M1 related gene suppression is
commonly associated with blockage of NF-κB co-
activators [52]. Our experiments tested NF-κB activity in
Fig. 2 HCV antigen pre-stimulation influences macrophage polarization in vitro. THP-1 cells were incubated with or without HCV antigens
(HCVcc, core protein or NS3/4A) after PMA stimulated macrophage differentiation. Adherent cells were then treated with LPS/IFN-γ medium for
M1-polarization before analysis. TNF-α (a), TfR1 (b), CD163 (c), CD23 (d), MMPs (e) and CD100 (f) expression levels were measured by RT-PCR. IL-10
and IL-12 expression levels from the culture medium were measured by ELISA (g)
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NF-κB signaling occurred at a lower level (p65 phos-
phorylation) when pre-incubated with HCV antigens
(Fig. 3b). We further checked expression of the A20/
ABIN1/TAX1BP1 complex, which regulates NF-κB ac-
tivity. The data suggest that expression was distinctively
influenced by each antigen (Fig. 3a). The HCV core pro-
tein significantly enhanced A20 expression, while HCVcc
and NS3/4A contributed modestly. ABIN1 was up regu-
lated by all antigens, while NS3/4A contributed more to
efficiency. However, TAX1BP1 showed a slight reduction,
especially when stimulated by NS3/4A. As the A20/ABIN1
complex suppresses NF-κB through the regulation of ubi-
quitin, which targets TBK1/IKKi, the total effect of HCV
antigen stimulation should weaken NF-κB activity [28].
Enhanced A20/ABIN1 contributes to abnormal M1
polarization
We next determined whether overexpression of A20 and
ABIN1 during macrophage differentiation induced simi-
lar effects to HCV antigen stimulation. A20/ABIN1 were
overexpressed by adenovirus vectors in THP-1 cells and
stimulated with phorbol myristate acetate (PMA). The
expression efficiency was checked by co-expression
marker green fluorescent protein (GFP) (Additional file 2:
Figure S4). The overexpression of A20 and ABIN1 eachinhibited NF-κB activity, as expected, whereas co-
expression of the two proteins was more efficient. NF-κB
activity gradually reduced following 3-day PMA stimula-
tion (Fig. 4d). CD100, TfR1, IL-10, and IL-12 expression
declined, while CD163 increased after A20/ABIN1 overex-
pression, correlating with HCV antigen stimulation
(Fig. 4a, c). The influence on MMPs appears more compli-
cated, as core MMP2 and MMP3 antigens, and MMP7 in
the HCVcc group and MMP14 in all HCV antigens,
showed a similar response to A20/ABIN1 overexpression,
indicative of distinct regulatory mechanisms (Fig. 4b).
M2 inhibition of NF-κB/HIF-1α–dependent gene tran-
scription is dependent upon STAT3/STAT6 activation
[8]. During macrophage polarization, if A20/ABIN1 is
overexpressed, NF-κB may be suppressed because of a
negative A20/ABIN1 feedback loop, which may have
profound influences on polarized macrophages. During
HCV infection, HCV antigens exist in a number of or-
gans as well as peripheral blood [53], suggesting that
HCV stimulates A20/ABIN1-mediated inflammation via
macrophages.
A20/ABIN1 up-regulation dampens HCVcc phagocytosis
of M1 macrophages
As professional APCs, macrophages not only mediate
nonspecific responses against microbes, but also induce
Fig. 3 HCV antigen stimulation suppresses NF-κB activity in polarized
M1 macrophages. a The expressions of A20/ABIN1/TAX1BP1 were
distinctively influenced by each antigen. Core protein highly increases
A20 levels and NS3/4A enhances ABIN1 expression. TAX1BP1
shows a slight reduction trend by NS3/4A stimulation. b NF-κB
activity was down regulated by HCV antigen stimulation, with regard
to p65 phosphorylation
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entation. Macrophages present antigens that initiate B cell
activation. Phagocytosis plays an essential role in this and
is the first step of antigen presentation [54]. To examine
whether premature macrophage–HCV antigen interaction
impacts phagocytosis, stimulated THP-1 cells with or
without HCV-NS3/4A co-incubation were exposed to
HCVcc for 6 hours. Cells were harvested and analyzed by
flow cytometry. The results indicated that macrophages
exposed to NS3/4A generated fewer HCVcc particles, sug-
gesting reduced HCV phagocytosis (Fig. 5a and Additional
file 3: Figure S2). Because HCV antigens stimulate A20/
ABIN1 expression, we further suppressed A20 by RNAi
during stimulation and examined M1 phagocytosis activity
by flow cytometry. Interestingly, an enhanced expression
peak emerged, which suggests macrophage phagocytosis
was rescued by A20 knockdown, indicating that A20 up-
regulation contributes to reduced phagocytosis (Fig. 5b
and Additional file 4: Figure S3).
We next asked whether this reduction influenced viral
concentrations in the ECM, which may be related to viral
clearance. The culture medium viral titers were tested at
each time point and after 72 hours co-incubation. HCVcc
levels in antigen-exposed cells were significantly higher
than normal controls (p < 0.001), suggesting that HCV
clearance from ECM may be impaired (Fig. 5c). However,the extracellular medium viral titer did not change after
A20 knockdown, suggesting that phagocytosis activity and
ultimate ECM viral concentration may be determined by
different mechanisms (Fig. 5d, upper).
A20/ABIN1-mediated TfR1 reduction of macrophages is
associated with extracellular HCVcc concentrations
TfR1 is ubiquitously expressed in most tissues, connect-
ing the extracellular ironbound transferrin and endocytic
adaptor TTP to facilitate clathrin-dependent endocyto-
sis. Recent studies have shown that TfR1, besides its iron
balance function, also participates in HCV entry of in-
fected cells. As the A20/ABIN1 complex inhibits NF-κB
signaling, which in turn regulates TfR1 expression
through HIF-1 regulation, the change of HCV entry in
M1 macrophages may be caused by a variation in TfR1
expression [55]. However, TfR1 overexpression does not
rescue HCVcc phagocytosis from NS3/4A stimulated
macrophages (Fig. 5d, lower). Although macrophage
phagocytosis was rescued in A20 RNAi assays, the TfR1
expression level did not increase (Fig. 5e), suggesting
that the macrophage phagocytosis process is influenced
by A20/ABIN1 and is independent of a TfR1 mediated
process. Interestingly, although TfR1 does not play a role
in intracellular HCV endocytosis, it reduced the final
extracellular concentration, as TfR1 overexpression de-
creased ECM viral titer, indicating that TfR1 likely medi-
ates the active transport of HCVcc particles.
Discussion
Our study demonstrated that HCV-infected patients pos-
sess functionally defective M1 macrophages. Decreases in
TNF-α and TfR1 have positive effects on immune cell
activation and iron uptake activity ex vivo, indicating sup-
pression of the M1-inflammatory response. Furthermore,
in vitro data indicated that HCV antigen exposure to
monocytes influenced M1-polarization by decreasing
IL-12, CD100 and TfR1, as well as up-regulating CD163
and MMPs, implying compromised cell polarization.
Thus, HCV antigen stimulation seems to inhibit inflam-
matory cytokines and iron uptake activity, facilitate anti-
inflammatory receptor expression; taken together this
characterizes an M1-polarization antagonized phenotype.
Notably, rather than inducing macrophage transformation
from M1 to M2, HCV stimulation caused a dysfunction of
the inflammatory process which both impair M1 and M2
polarization, regarding to weakened phagocytosis activity
(Fig. 5) which would be enhanced in transformation of
M1 to M2 [6–8].
The liver contains large numbers of tissue-resident mac-
rophages, Kupffer cells, which might be impacted simi-
larly. Kupffer cells contribute to immune regulation in the
liver. They express immune sensing receptors, through
which they contribute to inflammatory induction in the
Fig. 4 A20/ABIN1 overexpression contributes to abnormal M1 polarization. A20 and ABIN1 were over expressed in THP-1 cells (incubated with
LPS/IFN-γ before analysis) during PMA stimulation. a A20/ABIN1 over-expression reduced CD100 and TfR1 expression and CD163 was slightly up
regulated. b A20/ABIN1 over-expression influences MMPs expression differently. c IL-10 and IL-12 were decreased by A20/ABIN1 over-expression.
d Over-expression of A20 or ABIN1 inhibited NF-κB activity, and co-expression had a greater efficacy (upper). NF-κB activity was gradually reduced
at 3 days incubation (lower)
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same time, they also express potent anti-inflammatory cy-
tokines and contribute to the local regulation of innate
and adaptive immune responses [57–60]. HCV antigen
stimulation induces anti-inflammatory processes that con-
tribute to chronic HCV infection in the liver.
HCV-infected patients often exhibit insufficient im-
mune responses in the clinic. During the early stages of
infection, circulating HCV RNA is detected 3–7 days
after exposure, but seroconversion occurs weeks or
months after infection, implying HCV immune suppres-
sive effects. Indeed, humans possess a negative feedback
loop in response to inflammation. However, in HCV in-
fection, this negative response may be too sensitive to
stimulate an efficient inflammatory response, which re-
quires extra drugs such as PEG-IFN-α. According to our
data, the exposure of HCV antigens on monocytes prob-
ably contributes to anti-inflammatory processes during
HCV infection.
To further interpret the mechanism of HCV antigen
induced macrophage variation, NF-κB activity wasanalyzed. NF-κB signaling plays an essential role in
immune regulation and macrophage polarization [55].
Following HCV antigen stimulation, M1-polarized macro-
phages exhibited an A20/ABIN1 up-regulated phenotype,
which suppresses NF-κB activity. Antigen stimulation was
antigen-specific, as HCV core protein increased A20,
whereas NS3/4A up-regulatedABIN1. As expected, over-
expression of A20/ABIN1 generated a similar phenotype
to that by HCV antigen stimulation, including decreased
CD100, TfR1, IL-10 and IL-12 expression, and increased
CD163 and MMP14 expression, as well as reduced phago-
cytosis. Summarily, A20/ABIN1 up-regulation induced by
HCV antigens suppressed NF-κB activity and influenced
macrophage differentiation.
Interestingly, A20 knockdown rescued phagocytosis,
but had less effect on medium virus concentrations,
whereas TfR1 overexpression reduced extracellular viral
load. The iron regulator TfR1 is an important HCV entry
factor [55]; thus, TfR1 may be involved in macrophage-
mediated HCV phagocytosis, or may impact HCV clear-
ance via the ECM.
Fig. 5 A20 and TfR1 affect macrophage phagocytosis activity differently. a NS3/4A stimulated macrophages endocytosed fewer HCVcc particles.
b A20 suppression by RNA interference rescues phagocytosis activity. In contrast, TfR1 over-expression did not rescue phagocytosis. c Viral titers
in culture medium from HCV antigens stimulation were significantly higher than normal controls (p < 0.001). d TfR1 over-expression, but not A20
knockdown, reduces viral load extracellularly. e A20 knockdown cannot rescue TfR1 expression at the transcription level
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Subjects
Study subject information is summarized in Additional
file 5: Table S1. The first group comprised 30 female
healthy donors, the second group included 7 HCV-
infected patients who were untreated (treatment-naive pa-
tients), and the third group included 32 patients who had
been undergoing IFN-α/ribavarin antiviral therapy for 1–6
months (patients receiving antiviral treatment, PT). All
patients and healthy donors were negative for HIV and
hepatitis B virus. Testing of ALT and HCV viral load was
performed by the Department of Infectious Diseases at
Tangdu Hospital. The protocol conformed to the ethical
guidelines of 1975 Declaration of Helsinki and was
approved by the Research and Ethical Committee of
Tangdu Hospital of the Fourth Military Medical University.
Informed consent was obtained from all donors.
Cells and stimulation
PBMCs were isolated from blood with Ficoll-Hypaque
density centrifugation (Sigma, St Louis, MO, USA) ac-
cording to the manufacturer’s protocol. Healthy do-
nors PBMCs were cultured with X-vivo 15 medium
(Lonza, Walkersville, MD, USA) or stimulation medium
(X-vivo 15 containing HCV-core protein and NS3/4A,American Research Products Inc. Waltham, MA, USA)
for 1 day and were then treated with LPS/IFN-γ for M1
polarization. Patient PBMCs were cultured with X-vivo 15
medium for 1 day prior to LPS/IFN-γ M1 polarization.
THP-1 cells cultured in RPMI 1640 (Mediatech Inc,
Manassas, VA, USA) were obtained from ATCC (Manas-
sas, VA, USA). Huh7.5 human hepatoma cells (ATCC)
were grown in Dulbecco’s Modified Eagle’s Medium
(Mediatech Inc.) containing 10 % fetal bovine serum
(Life Technologies, Grand Island, NY, USA), 100 μg/ml
penicillin–streptomycin, 0.05 mM β-mercaptoethanol
and 2 mM L-glutamine (Mediatech Inc.). Cells were
cultured at 37 °C with 5 % CO2. For cell stimulation,
THP1 cells were cultured for 3 days in 1640 medium
with PMA for differentiation [61, 62] with or without
HCV-core, NS3/4A (American Research Products Inc.
Waltham, MA, USA) or HCVcc. Cells were then cultured
in RPMI 1640 containing IFN-γ/LPS for M1 polarization
[63–65] 1 day before analysis.
HCVcc generation and vector construction
HCVcc was generated by transfection of the HCV pJFH1
transcript (generated by TranscriptAid T7 High Yield
Transcription kit, ThermoFisher Scientific, Waltham,
MA, US) into Hu7.5 cells using DMRIE-C reagents
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adenovirus (ad-A20 and ad-ABIN1), A20 RNAi lentiviral
(le-A20i), and TfR1 (pGV146-tfr1) overexpression vec-
tors were purchased from Genechem Co. Ltd (Shanghai,
China).
Western blotting
Cells were harvested in lysis buffer (50 mM Tris–HCl at
pH 7.5, 150 mM NaCl, 2 mM EDTA) supplemented with
protease inhibitor (Roche Applied Science, Indianapolis,
IN, USA). Lysate was run by 10 % sodium dodecyl
sulfate polyacrylamide gel electrophoresis and transferred
to polyvinylidene difluoride membranes (Immobilon-P,
Millipore, Billerica, MA, USA). Membranes were blocked
with 5 % (wt/vol) non-fat milk followed by incubation
with primary antibodies (p-NF-κB p65 mouse mAb, Cell
Signaling, Danvers, MA, USA) and secondary antibody
(horseradish peroxidase-conjugated goat anti-mouse,
Abgent, San Diego, CA, USA). Membranes probed with
β-actin monoclonal antibody (Bioworld Technology, St.
Louis Park, MN, USA) served as a control.
Immunofluorescence
Cells in chamber slide wells were fixed with paraformalde-
hyde and stained as follows. Primary antibodies against
TfR1 (eBioscience, San Diego, CA, USA) and HCV core
(mAb to HCV core Antigen, Abcam, Cambridge, MA,
USA) were incubated at a 1:2000 dilution overnight
at 4 °C. Conjugated secondary antibodies (anti-mouse
Alexa-555, Abcam) were incubated at a 1:1000 dilution for
1 h at room temperature. Nuclei were stained with 4′,6-
diamidino-2-phenylindole (DAPI). Images were captured
via confocal microscopy (BX51-DP70 system, Olympus,
Tokyo, Japan) and analyzed using Olympus DP Controller
and Management software.
RNA isolation and RT-PCR Analysis
RNA was purified using RNeasy Mini Kit (Qiagen,
Gaithersburg, MD, USA) according to the manufacturer’s
instructions. After DNase I (Invitrogen) treatment, cDNA
was synthesized by RevertAid First Strand cDNA Synthesis
Kit (ThermoFisher Scientific) following the manufacturer’s
protocol. Gene expression was measured by RT-qPCR with
SYBR Premix Ex Taq II (Takara, Mountain View, CA,
USA), using Bio-Rad iQ5 Real-time Thermocycler as
described (Bio-Rad, Hercules, CA, USA). Expression
levels were determined relative to a standard curve and
normalized to GAPDH. Primer sequences are shown in
Additional file 6: Table S2.
Flow cytometry
Cells were fixed with 2 % paraformaldehyde and perme-
able reagent (eBioscience) for 30 min on ice. Cells were
stained with fluorescently labeled antibodies (1 μg/ml;1 h at room temperature), assayed by flow cytometry
(FASCAria II, BD Bioscience, Franklin Lakes, NJ, USA),
and data were analyzed by Flowjo7.6 software (Tree Star,
Inc. Ashland, OR, USA). Primary antibodies used for
staining were anti-human cd71-FITC (eBioscience), mAb
to HCV core Antigen (Abcam), and goat anti-mouse
Alexa555 antibody (Abcam).
ELISA
IL-10 and IL-12 concentrations in stimulated cell culture
medium were determined by human IL-10 or IL-12 Plat-
inum ELISA kit (eBioscience). Duplicate standard curves
were prepared as follows. Briefly, diluted standard pro-
teins were added to plates, incubated at 4 °C overnight,
blocked, and antibodies were added. After addition of
substrate solution, reactions were stopped by adding
25 μl 2 M H2SO4. Results were detected by micro-plate
reader (BioTek; Shanghai, China) and IL-10 and IL-12
concentrations were calculated against the standard
curve by CurveExpert1.3 [19].
Statistical analysis
One-way ANOVA and Student’s t-test were used to de-
termine statistical significance. Analyses were performed
with GraphPad Prism Version 5.0 (La Jolla, CA, USA)
and SPSS Statistics 21.0 (IBM Corp., Armonk, NY,
USA). A p value < 0.05 was considered statistically
significant.
Conclusions
In summary, this study demonstrated that HCV antigens
impact M1 macrophage polarization. After antigen
stimulation, NF-κB signaling is suppressed by up-
regulation of the A20/ABIN1 complex, which leads to
variation of functional molecules such as CD163, MMPs,
TfR1, and CD100, indicating an anti-inflammatory reac-
tion against M1-polarization.
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